PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis
The DOI matches its Crossref record; 108 of the 109 references it cites were found in a registry or an index.
Abstract
BACKGROUND Current knowledge about the consequences of PCOS during the late reproductive years and after menopause is limited. OBJECTIVE AND RATIONALE We performed a systematic review and meta-analysis of data on the pathophysiology, clinical manifestations, diagnosis, prognosis, and treatment of women ≥45 years of age-peri- or postmenopausal-with PCOS. SEARCH METHODS Studies published up to 15 April 2023, identified by Entrez-PubMed, EMBASE, and Scopus online facilities, were considered. We included cross-sectional or prospective studies that reported data from peri- or postmenopausal patients with PCOS and control women with a mean age ≥45 years. Three independent researchers performed data extraction. Meta-analyses of quantitative data used random-effects models because of the heterogeneity derived from differences in study design and criteria used to define PCOS, among other confounding factors. Sensitivity analyses restricted the meta-analyses to population-based studies, to studies including only patients diagnosed using the most widely accepted definitions of PCOS, only menopausal women or only women not submitted to ovarian surgery, and studies in which patients and controls presented with similar indexes of weight excess. Quality of evidence was assessed using the GRADE system. OUTCOMES The initial search identified 1400 articles, and another six were included from the reference lists of included articles; 476 duplicates were deleted. We excluded 868 articles for dif…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PCOS has been recognized recently as a lifelong disease affecting individuals into the postmenopausal years.35, 36, 37, 38, 39”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [36]
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
McGuinness, L. A., & Higgins, J. P. T. (2021) · Research Synthesis Methods · doi:10.1002/jrsm.1411 · Cited by 5,579
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citationPolycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Self-citationDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Self-citationViechtbauer, W. (2007) · Psychometrika · doi:10.1007/s11336-006-1450-y · Cited by 1,250
The normal menopause transition
McKinlay, S. M., Brambilla, D. J., & Posner, J. G. (1992) · Maturitas · doi:10.1016/0378-5122(92)90003-m · Cited by 1,109
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Self-citationYildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I., & Yarali, H. (2012) · Human Reproduction · doi:10.1093/humrep/des232 · Cited by 704
Barry, J. A., Azizia, M. M., & Hardiman, P. J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu012 · Cited by 597
Talbott, E. O., Guzick, D. S., Sutton-Tyrrell, K., McHugh-Pemu, K. P., Zborowski, J. V., Remsberg, K. E., & Kuller, L. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2414 · Cited by 511
Lipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.027 · Cited by 477
Cancer burden in the aged: An epidemiologic and demographic overview
Yancik, R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1273::aid-cncr13>3.0.co;2-4 · Cited by 473
Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Odén, A., Janson, P. O., Mattson, L.-Å., Crona, N., & Lundberg, P.-A. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54892-4 · Cited by 470
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa029 · Cited by 425
Abdominal adiposity and the polycystic ovary syndrome
Escobar-Morreale, H. F., & Millán, J. L. S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.003 · Cited by 386
Self-citationTalbott, E., Clerici, A., Berga, S. L., Kuller, L., Guzick, D., Detre, K., Daniels, T., & Engberg, R. A. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00010-9 · Cited by 315
Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study
Wild, S., Pierpoint, T., Jacobs, H., & McKeigue, P. (2000) · Human Fertility · doi:10.1080/1464727002000198781 · Cited by 306
Talbott, E. O., Zborowski, J. V., Rager, J. R., Boudreaux, M. Y., Edmundowicz, D. A., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032237 · Cited by 273
Cibula, D. (2000) · Human Reproduction · doi:10.1093/humrep/15.4.785 · Cited by 267
Townsend, M. F., Sanders, W. H., Northway, R. O., & Graham, S. D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<545::aid-cncr17>3.0.co;2-3 · Cited by 260
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv063 · Cited by 255
Elting, M. W., Korsen, T. J. M., Bezemer, P. D., & Schoemaker, J. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.556 · Cited by 254
Schmidt, J., Landin-Wilhelmsen, K., Brännström, M., & Dahlgren, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1677 · Cited by 241
Polycystic ovary syndrome and cancer
Balen, A. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.6.522 · Cited by 218
Escobar-Morreale, H. F., Sanchón, R., & San Millán, J. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2053 · Cited by 186
Self-citationOllila, M.-M. E., Piltonen, T., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., & Morin-Papunen, L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3543 · Cited by 182
Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome
Winters, S. J., Talbott, E., Guzick, D. S., Zborowski, J., & McHugh, K. P. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00641-x · Cited by 182
Variation in symptoms of depression and anxiety in midlife women by menopausal status
Mulhall, S., Andel, R., & Anstey, K. J. (2018) · Maturitas · doi:10.1016/j.maturitas.2017.11.005 · Cited by 173
Ollila, M.-M. E., West, S., Keinänen-Kiukaanniemi, S., Jokelainen, J., Auvinen, J., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dew329 · Cited by 165
Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause
Welt, C. K., & Carmina, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2375 · Cited by 148
Amiri, M., Ramezani Tehrani, F., Behboudi-Gandevani, S., Bidhendi-Yarandi, R., & Carmina, E. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00576-1 · Cited by 136
Meun, C., Franco, O. H., Dhana, K., Jaspers, L., Muka, T., Louwers, Y., Ikram, M. A., Fauser, B. C. J. M., Kavousi, M., & Laven, J. S. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02421 · Cited by 126
Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age
Alsamarai, S., Adams, J. M., Murphy, M. K., Post, M. D., Hayden, D. L., Hall, J. E., & Welt, C. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0839 · Cited by 122
Karjula, S., Morin-Papunen, L., Auvinen, J., Ruokonen, A., Puukka, K., Franks, S., Järvelin, M.-R., Tapanainen, J. S., Jokelainen, J., Miettunen, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3863 · Cited by 122
Schmidt, J., Brännström, M., Landin-Wilhelmsen, K., & Dahlgren, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2959 · Cited by 113
Polycystic Ovaries and the Risk of Breast Cancer
Gammon, M. D., & Thompson, W. D. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116156 · Cited by 113
Human ovarian theca cells in culture
Wickenheisser, J. K., Nelson-DeGrave, V. L., & McAllister, J. M. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.01.003 · Cited by 112
Krentz, A. J., von Mühlen, D., & Barrett-Connor, E. (2007) · Menopause · doi:10.1097/gme.0b013e31802cc7ab · Cited by 110
Zhu, S., Zhang, B., Jiang, X., Li, Z., Zhao, S., Cui, L., & Chen, Z.-J. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.09.013 · Cited by 109
Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108
Hormone-related factors and gynecological conditions in relation to endometrial cancer risk
Zucchetto, A., Serraino, D., Polesel, J., Negri, E., De Paoli, A., Dal Maso, L., Montella, M., La Vecchia, C., Franceschi, S., & Talamini, R. (2009) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328329d830 · Cited by 108
Hyperandrogenism in Women with Polycystic Ovary Syndrome Persists after Menopause
Markopoulos, M. C., Rizos, D., Valsamakis, G., Deligeoroglou, E., Grigoriou, O., Chrousos, G. P., Creatsas, G., & Mastorakos, G. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0130 · Cited by 107
MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
Markopoulos, M. C., Kassi, E., Alexandraki, K. I., Mastorakos, G., & Kaltsas, G. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0468 · Cited by 105
Polycystic ovary syndrome: evolution of a concept
Ruutiainen, K., & Seppälä, M. (1991) · Current Opinion in Obstetrics and Gynecology · doi:10.1097/00001703-199106000-00004 · Cited by 99
Talbott, E. O., Zborowski, J. V., Boudreaux, M. Y., McHugh-Pemu, K. P., Sutton-Tyrrell, K., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032110 · Cited by 99
Ding, D.-C., Chen, W., Wang, J.-H., & Lin, S.-Z. (2018) · Medicine · doi:10.1097/md.0000000000012608 · Cited by 96
Pinola, P., Piltonen, T. T., Puurunen, J., Vanky, E., Sundström-Poromaa, I., Stener-Victorin, E., Ruokonen, A., Puukka, K., Tapanainen, J. S., & Morin-Papunen, L. C. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2123 · Cited by 91
Ramezani Tehrani, F., Amiri, M., Behboudi-Gandevani, S., Bidhendi-Yarandi, R., & Carmina, E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1650337 · Cited by 91
Merz, C. N. B., Shaw, L. J., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5441 · Cited by 87
Puurunen, J., Piltonen, T., Jaakkola, P., Ruokonen, A., Morin-Papunen, L., & Tapanainen, J. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2583 · Cited by 85
Luque-Ramírez, M., Álvarez-Blasco, F., Mendieta-Azcona, C., Botella-Carretero, J. I., & Escobar-Morreale, H. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0190 · Cited by 82
Self-citationHemostatic and metabolic variables in women with polycystic ovary syndrome
Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., Lindstedt, G., & Tengborn, L. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56575-3 · Cited by 81
Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women
Elhassan, Y. S., Idkowiak, J., Smith, K., Asia, M., Gleeson, H., Webster, R., Arlt, W., & O’Reilly, M. W. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02426 · Cited by 80
Management of Postmenopausal Virilization
Alpañés, M., González-Casbas, J. M., Sánchez, J., Pian, H. G., & Escobar-Morreale, H. F. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1683 · Cited by 75
Self-citationForslund, M., Landin-Wilhelmsen, K., Trimpou, P., Schmidt, J., Brännström, M., & Dahlgren, E. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoz042 · Cited by 66
The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
Meun, C., Gunning, M. N., Louwers, Y. V., Peters, H., Roos‐Hesselink, J., Roeters van Lennep, J., Rueda Ochoa, O., Appelman, Y., Lambalk, N., Boersma, E., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14117 · Cited by 65
Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
Gabrielli, L., & Aquino, E. M. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-96 · Cited by 63
Forslund, M., Landin‐Wilhelmsen, K., Schmidt, J., Brännström, M., Trimpou, P., & Dahlgren, E. (2019) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13489 · Cited by 60
Talbott, E. O. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1452 · Cited by 59
Hendriks, M. L., Ket, J. C. F., Hompes, P. G. A., Homburg, R., & Lambalk, C. B. (2007) · Human Reproduction Update · doi:10.1093/humupd/dml058 · Cited by 57
Polycystic ovaries in pre and post‐menopausal women
Birdsall, M. A., & Farquhar, C. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.676498.x · Cited by 56
Prediction of age at menopause in women with polycystic ovary syndrome
Minooee, S., Ramezani Tehrani, F., Rahmati, M., Mansournia, M. A., & Azizi, F. (2018) · Climacteric · doi:10.1080/13697137.2017.1392501 · Cited by 55
Common diseases as determinants of menopausal age
Li, J., Eriksson, M., Czene, K., Hall, P., & Rodriguez-Wallberg, K. A. (2016) · Human Reproduction · doi:10.1093/humrep/dew264 · Cited by 53
Ollila, M.-M. E., Kaikkonen, K., Järvelin, M.-R., Huikuri, H. V., Tapanainen, J. S., Franks, S., Piltonen, T. T., & Morin-Papunen, L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00570 · Cited by 53
Anagnostis, P. G., Paparodis, R. D., Bosdou, J. Κ., Bothou, C., Μacut, D., Goulis, D. G., & Livadas, S. (2021) · Endocrine · doi:10.1007/s12020-021-02801-2 · Cited by 52
Metabolic profile in women with polycystic ovary syndrome across adult life
Echiburú, B., Crisosto, N., Maliqueo, M., Pérez-Bravo, F., de Guevara, A. L., Hernández, P., Cavada, G., Rivas, C., Clavel, A., & Sir-Petermann, T. (2016) · Metabolism · doi:10.1016/j.metabol.2016.01.006 · Cited by 50
Karjula, S., Morin-Papunen, L., Franks, S., Auvinen, J., Järvelin, M.-R., Tapanainen, J. S., Jokelainen, J., Miettunen, J., & Piltonen, T. T. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz256 · Cited by 49
Schmidt, J., Dahlgren, E., Brännström, M., & Landin‐Wilhelmsen, K. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04378.x · Cited by 48
Kim, J., Mersereau, J. E., Khankari, N., Bradshaw, P. T., McCullough, L. E., Cleveland, R., Shantakumar, S., Teitelbuam, S. L., Neugut, A. I., Senie, R. T., et al. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0716-7 · Cited by 48
Hyperandrogenic Oligomenorrhea and Metabolic Risks Across Menopausal Transition
Polotsky, A. J., Allshouse, A. A., Crawford, S. L., Harlow, S. D., Khalil, N., Kazlauskaite, R., Santoro, N., & Legro, R. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4170 · Cited by 47
Armeni, E., Stamatelopoulos, K., Rizos, D., Georgiopoulos, G., Kazani, M., Kazani, A., Kolyviras, A., Stellos, K., Panoulis, K., Alexandrou, A., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283630362 · Cited by 46
Polotsky, A. J., Allshouse, A., Crawford, S. L., Harlow, S. D., Khalil, N., Santoro, N., & Legro, R. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3357 · Cited by 44
Falcetta, P., Benelli, E., Molinaro, A., Cosmo, C. D., Bagattini, B., Ghianda, S. D., Salvetti, G., Fiore, E., Pucci, E., Fruzzetti, F., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01594-5 · Cited by 40
Kujanpää, L., Arffman, R. K., Pesonen, P., Korhonen, E., Karjula, S., Järvelin, M., Franks, S., Tapanainen, J. S., Morin‐Papunen, L., & Piltonen, T. T. (2022) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.14382 · Cited by 40
Morbidity and mortality in PCOS: A prospective follow-up up to a mean age above 80 years
Forslund, M., Schmidt, J., Brännström, M., Landin‐Wilhelmsen, K., & Dahlgren, E. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.02.020 · Cited by 39
Ortiz-Flores, A. E., Luque‐Ramírez, M., Fernández‐Durán, E., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2019) · Metabolism · doi:10.1016/j.metabol.2019.01.015 · Cited by 38
Self-citationPolycystic ovary syndrome in post-menopausal women—marker of the metabolic syndrome
Margolin, E., Zornitzki, T., Kopernik, G., Kogan, S., Schattner, A., & Knobler, H. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.09.005 · Cited by 37
Women younger than 50 years with endometrial cancer.
Iatrakis, G. M., Zervoudis, S., Saviolakis, A., Τρούλος, Μ., Antoniou, E., Sarantaki, A., Lykeridou, A., & Kourounis, G. (2006) · PubMed · Cited by 36
Referral bias in female functional hyperandrogenism and polycystic ovary syndrome
Luque-Ramírez, M., Alpañés, M., Sanchón, R., Fernández-Durán, E., Ortiz-Flores, A. E., & Escobar-Morreale, H. F. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0646 · Cited by 35
Self-citationLuque-Ramírez, M., Martí, D., Fernández-Durán, E., Alpañés, M., Álvarez-Blasco, F., & Escobar-Morreale, H. F. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02468 · Cited by 35
Self-citationThe impact of ageing and menopause in women with polycystic ovary syndrome
Helvaci, N., & Yildiz, B. O. (2022) · Clinical Endocrinology · doi:10.1111/cen.14558 · Cited by 32
Forslund, M., Schmidt, J., Brännström, M., Landin‐Wilhelmsen, K., & Dahlgren, E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa840 · Cited by 31
Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome
Cheang, K. I., Nestler, J. E., & Futterweit, W. (2008) · Endocrine Practice · doi:10.4158/ep.14.9.1084 · Cited by 31
Heart health in polycystic ovary syndrome: time to act on the data
Dokras, A. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.014 · Cited by 23
Markopoulos, M. C., Valsamakis, G., Kouskouni, E., Boutsiadis, A., Papassotiriou, I., Creatsas, G., & Mastorakos, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0550 · Cited by 20
Snyder, M., Shields, K. J., Korytkowski, M. T., Sutton‐Tyrrell, K., & Talbott, E. O. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.895985 · Cited by 18
Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome
Hernández‐Mijares, A., Bañuls, C., Gómez‐Balaguer, M., Bergoglio, M. T., Víctor, V. M., & Rocha, M. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12080 · Cited by 18
Livadas, S., Μacut, D., Bothou, C., Kuliczkowska-Płaksej, J., Vryonidou, A., Bjekić-Macut, J., Mouslech, Z., Milewicz, A., & Panidis, D. (2020) · HORMONES · doi:10.1007/s42000-020-00211-z · Cited by 16
Polycystic ovary syndrome and leukocyte telomere length: cross-sectional and longitudinal changes
Pölönen, J., Pinola, P., Ronkainen, J., Blakemore, A. I. F., Buxton, J. L., Tapanainen, J. S., Franks, S., Piltonen, T., Sebert, S. P., & Morin-Papunen, L. C. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0462 · Cited by 16
Premature Aging of Cardiovascular/Platelet Function in Polycystic Ovarian Syndrome
Chan, W. P. A., Ngo, D. T. M., Sverdlov, A. L., Rajendran, S., Stafford, I., Heresztyn, T., Chirkov, Y. Y., & Horowitz, J. D. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.015 · Cited by 15
Guoqing, Z., Sun, F., Lihui, D., Bing, Y., Peng, Q., Yingting, W., & Jinxia, L. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2016.1149812 · Cited by 15
Krentz, A. J., von Mühlen, D. G., & Barrett-Connor, E. L. (2012) · Metabolism · doi:10.1016/j.metabol.2012.02.001 · Cited by 13
Kim, C., Aroda, V. R., Goldberg, R. B., Younes, N., Edelstein, S. L., Carrion-Petersen, M. L., Ehrmann, D. A., & Diabetes Prevention Program Outcomes Study Group (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01829 · Cited by 12
High androgen levels protect against hypothyroidism
Schmidt, J., Dahlgren, E., Bryman, I., Berntorp, K. E., Trimpou, P., Wilhelmsen, L., & Landin‐Wilhelmsen, K. (2016) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13054 · Cited by 10
Association between polycystic ovary syndrome and hot flash presentation during the midlife period
Yin, O., Zacur, H. A., Flaws, J. A., & Christianson, M. S. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001055 · Cited by 10
Gabrielli, L., de Almeida, M. D. C. C., & Aquino, E. M. L. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.04.013 · Cited by 7
Health-Related Quality of Life in perimenopausal women with PCOS
Forslund, M., Landin‐Wilhelmsen, K., Krantz, E., Trimpou, P., Schmidt, J., Brännström, M., & Dahlgren, E. (2022) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4902052 · Cited by 7
Persson, S., Ubhayasekera, K. A., Bergquist, J., Türkmen, Ş., Poromaa, I. S., & Elenis, E. (2022) · Biomedicines · doi:10.3390/biomedicines11010096 · Cited by 7
Forslund, M., Landin‐Wilhelmsen, K., Brännström, M., & Dahlgren, E. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.04.008 · Cited by 5
Reduced serum ghrelin in a putative postmenopausal polycystic ovary syndrome phenotype
Krentz, A. J., & Barrett-Connor, E. L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.039 · Cited by 5
Deniz, A., & Kehribar, L. (2021) · PubMed · doi:10.26355/eurrev_202108_26446 · Cited by 3
Research works printed but not linked: 4
- Anderson, 1997, Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa, Cancer, 79, 494, 10.1002/(sici)1097-0142(19970201)79:3<494::aid-cncr10>3.0.co;2-z · DOI · Paper page
- Parazzini, 1997, Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa, Cancer, 80, 1360, 10.1002/(sici)1097-0142(19971001)80:7<1360::aid-cncr28>3.3.co;2-x · doi:10.1002/(sici)1097-0142(19971001)80:7<1360::aid-cncr28>3.3.co;2-x
- Sterne, 2005, Publication Bias in Meta-Analysis – Prevention, Assessment and Adjustments
- Zawadzki, 1992, Polycystic Ovary Syndrome
Cited by
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“Despite the high prevalence of PCOS, with hyperandrogenism and hyperinsulinaemia persisting even after menopause 13 , it can take Box 1”
InfluentialPolycystic ovary syndrome as a metabolic disease
Helvaci, N., & Yildiz, B. O. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 188
Tay, C. T., Mousa, A., Vyas, A., Pattuwage, L., Tehrani, F. R., & Teede, H. J. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033572 · Cited by 154
Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities
Zhang, Y., Chen, Z., & Zhao, H. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.08.002 · Cited by 66
Epigenetic/circadian clocks and PCOS
Vatier, C., & Christin‐Maître, S. (2024) · Human Reproduction · doi:10.1093/humrep/deae066 · Cited by 65
Metadata
- Authors
- Millán-de-Meer, M., Luque-Ramírez, M., Nattero-Chávez, L., & Escobar-Morreale, H. F.
- Affiliations
- Universidad de Alcalá (ES)
- Universidad de Alcalá , Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal , Madrid, Spain
- Corresponding author
- Escobar-Morreale, Héctor F
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-06-23
- Volume
- 29
- Issue
- 6
- Pages
- 741-772
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W4381839434
- Cited by
- 82
- References
- 109
- Citations by year
- 2026: 32 · 2025: 29 · 2024: 14 · 2023: 7
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Instituto de Salud Carlos III (PI18/01122, PI21/00116)
- European Development Regional Fund
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, menopause, postmenopausal women, perimenopausal women, testosterone, free androgen index, androstenedione, sex hormone-binding globulin, insulin resistance, hyperandrogenism, obesity, cardiovascular risk, dyslipidemia, cardiovascular mortality, PCOS treatment, PCOS diagnosis, PCOS pathophysiology
- MeSH terms
- Androgens, Cholesterol, Cross-Sectional Studies, Female, Humans, Menopause, Middle Aged, Obesity, Polycystic Ovary Syndrome, Prospective Studies, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.